
INVO, Heidi Health Partner for AI Fertility Tools
INVO Fertility, a healthcare fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses

INVO Fertility, a healthcare fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics and related businesses

Dandy, a fully digital dental lab, unveiled two new products for digital dentistry: the revolutionary Dandy Vision intraoral scanner and the powerful all-in-one touchscreen DandyCart.

Adding WINREVAIR to background PAH therapy improved exercise capacity and WHO functional class (FC), and reduced the risk of clinical worsening events, including hospitalization for

Bristol Myers Squibb announced Week 52 data from the pivotal Phase 3 POETYK PsA-1 trial further confirming the efficacy and safety of Sotyktu (deucravacitinib) in adults with

Wellpoint DC announced that it has been awarded Full Health Plan Accreditation by the National Committee for Quality Assurance (NCQA) for its Medicaid HMO, effective

CareDx, Inc., The Transplant Company — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for

Wilmington PharmaTech, a U.S.-based specialty contract research, development and manufacturing organization (CRDMO) focused on complex custom small molecule API, announced the appointment of Kent Payne,

Incyte, which is listed on as INCY, and Enable Injections, Inc. have announced a strategic partnership to move forward with certain therapies from Incyte’s pipeline,

Convatec, a major company that makes medical products and technologies for people with long-term health issues, has published a new report showing the social challenges

Dispersive Holdings, Inc., a leading company in stealth networking and secure communications that work even after quantum computers are developed, announced that it has finished

Takeda announced that the recently FDA-approved HyHub and HyHub Duo devices are now available in the U.S. for patients 17 years of age and older,

Bahrain Mumtalakat Holding Company BSC(c), the country’s sovereign wealth fund, has partnered with SandboxAQ, a leading global company in artificial intelligence and quantum technologies, to